Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zimeldine induced neuropathies.

S L Dexter

    Human Toxicology
    |April 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Zimeldine, a new antidepressant, may cause neuropathies. Two patients developed nerve damage within a week of starting this selective serotonin reuptake inhibitor.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of food enrichment on cage side preference.

    Laboratory animal science·1994
    Same author

    The Effects of Food Treat Provisioning and Human Interaction on the Behavioral Wel1-being of Rhesus Monkeys (Macaca mulatta).

    Contemporary topics in laboratory animal science·1993
    Same author

    Kong toys for laboratory primates: are they really an enrichment or just fomites?

    Laboratory animal science·1993
    Same author

    Evaluation of the preference to and behavioral effects of an enriched environment on male rhesus monkeys.

    Laboratory animal science·1992
    Same author

    Double-blind controlled study of paramax in the acute treatment of common and classical migraine.

    The British journal of clinical practice·1985
    Same author

    Rebreathing aborts migraine attacks.

    British medical journal (Clinical research ed.)·1982
    Same journal

    Intracellular localization of cerium. A microanalytical study using an electron microprobe and ionic microanalysis.

    Human toxicology·1989
    Same journal

    Self-poisoning in Sri Lanka: factors determining the choice of the poisoning agents.

    Human toxicology·1989
    Same journal

    The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone).

    Human toxicology·1989
    Same journal

    Pharmacokinetics and toxic effects of diltiazem in massive overdose.

    Human toxicology·1989
    Same journal

    Acute renal failure following accidental cutaneous absorption of phenol: application of NMR urinalysis to monitor the disease process.

    Human toxicology·1989
    Same journal

    Toxicological data after heroin overdose.

    Human toxicology·1989
    See all related articles

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Clinical Neurology

    Background:

    • Zimeldine is a novel pyridylallylamine antidepressant.
    • It selectively inhibits 5-hydroxytryptamine (serotonin) re-uptake.
    • This mechanism targets central nerve synapses to alleviate depressive symptoms.

    Observation:

    • Two patients were observed to develop neuropathies.
    • The onset of neuropathies occurred within one week of initiating Zimeldine treatment.
    • This adverse effect has not been previously documented.

    Findings:

    • A potential association between Zimeldine and the development of neuropathies is reported.
    • The rapid onset suggests a possible drug-induced neurological reaction.
    • Further investigation is warranted to confirm causality.

    Implications:

    • This finding highlights a potential safety concern for Zimeldine.
    • Clinicians should be vigilant for neurological side effects in patients taking Zimeldine.
    • This may necessitate a re-evaluation of Zimeldine's risk-benefit profile.